1. Antibody Response of Heterologous vs Homologous Messenger RNA Vaccine Boosters Against the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant: Interim Results from the PRIBIVAC Study, a Randomized Clinical Trial. (11th May 2022) Authors: Poh, Xuan Ying; Tan, Chee Wah; Lee, I Russel; Chavatte, Jean-Marc; Fong, Siew-Wai; Prince, Tessa; Hartley, Catherine; Yeoh, Aileen Y Y; Rao, Suma; Chia, Po Ying; Ong, Sean W X; Lee, Tau Hong; Sadarangani, Sapna P; Lin, Ray J H; Lim, Clarissa; Teo, Jefanie; Lim, Daniel R X; Chia, Wanni; Hiscox, Ju... Journal: Clinical infectious diseases Issue: Volume 75:Number 12(2022) Page Start: 2088 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗